MEDICINA
Departamento
Institut d'Investigació Sanitària Pere Virgili
Reus, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Sanitària Pere Virgili (14)
2023
-
Impact of COVID-19 pandemic on the PREDIMED-Plus randomized clinical trial: Effects on the interventions, participants follow-up, and adiposity
Frontiers in Nutrition, Vol. 9
-
Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial
Atherosclerosis, Vol. 377, pp. 12-23
2022
2020
-
Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study
European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206
2019
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
2018
-
Cancer survival in adult patients in Spain. Results from nine population-based cancer registries
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211
-
Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301
-
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
PLoS ONE, Vol. 13, Núm. 6
2017
-
Cancer incidence in Spain, 2015
Clinical and Translational Oncology, Vol. 19, Núm. 7, pp. 799-825
-
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007
Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 301-316
2012
-
Lung cancer prognosis in Spain: The role of histology, age and sex
Respiratory Medicine, Vol. 106, Núm. 9, pp. 1301-1308
2010
-
Cancer survival in Spain: Estimate for nine major cancers
Annals of Oncology, Vol. 21, Núm. SUPPL.3
-
Changes in colorectal cancer incidence and mortality trends in Spain
Annals of Oncology, Vol. 21, Núm. SUPPL.3
-
Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: Impact on mortality
Annals of Oncology, Vol. 21, Núm. SUPPL.3